154 related articles for article (PubMed ID: 23060308)
1. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study.
Tuzun S; Eskiyurt N; Akarirmak U; Saridogan M; Johansson H; McCloskey E; Kanis JA;
Arch Osteoporos; 2012; 7():229-35. PubMed ID: 23060308
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
[TBL] [Abstract][Full Text] [Related]
3. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
[TBL] [Abstract][Full Text] [Related]
4. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
[TBL] [Abstract][Full Text] [Related]
5. FRAX-based intervention and assessment thresholds for osteoporosis in Romania.
Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
Arch Osteoporos; 2013; 8():164. PubMed ID: 24390553
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk.
Dimai HP; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; Fahrleitner-Pammer A; Pietschmann P; Muschitz C; McCloskey EV; Kanis JA
Arch Osteoporos; 2022 Nov; 17(1):141. PubMed ID: 36357621
[TBL] [Abstract][Full Text] [Related]
7. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
8. Incidence of hip fracture in Brazil and the development of a FRAX model.
Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
[TBL] [Abstract][Full Text] [Related]
9. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
[TBL] [Abstract][Full Text] [Related]
10. The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.
Badurski JE; Kanis JA; Johansson H; Dobreńko A; Nowak NA; Daniluk S; Jezienicka E
Pol Arch Med Wewn; 2011 May; 121(5):148-55. PubMed ID: 21610662
[TBL] [Abstract][Full Text] [Related]
11. Development and application of FRAX in the management of osteoporosis in Ireland.
McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
13. Use of age-dependent FRAX-based intervention thresholds for Singapore.
Kanis JA; Chandran M; Chionh SB; Ganeson G; Harvey NC; Koh WP; Kwok T; Lau TC; Liu E; Lorentzon M; McCloskey EV; Tan KB; Vandenput L; Johansson H
Arch Osteoporos; 2020 Jul; 15(1):104. PubMed ID: 32700118
[TBL] [Abstract][Full Text] [Related]
14. The application of FRAX in Saudi Arabia.
Al-Daghri NM; Sabico S; Al-Saleh Y; Sulimani R; Aljohani NJ; Sheshah E; Alodhayani A; Harvey NC; Liu E; Lorentzon M; McCloskey EV; Vandenput L; Johansson H; Kanis JA
Arch Osteoporos; 2021 Nov; 16(1):166. PubMed ID: 34739604
[TBL] [Abstract][Full Text] [Related]
15. Establishing and evaluating FRAX
Chan DC; McCloskey EV; Chang CB; Lin KP; Lim LC; Tsai KS; Yang RS
J Formos Med Assoc; 2017 Mar; 116(3):161-168. PubMed ID: 27117886
[TBL] [Abstract][Full Text] [Related]
16. FRAX-based intervention thresholds for Pakistan.
Johansson H; Naureen G; Iqbal R; Jafri L; Khan AH; Umer M; Liu E; Vandenput L; Lorentzon M; McCloskey EV; Kanis JA; Harvey NC
Osteoporos Int; 2022 Jan; 33(1):105-112. PubMed ID: 34414463
[TBL] [Abstract][Full Text] [Related]
17. An assessment of intervention thresholds for high fracture risk in Chile.
Gavilanez EL; Luis IN; Mario NG; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV; Kanis JA
Arch Osteoporos; 2022 Dec; 18(1):11. PubMed ID: 36527508
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX.
Horner K; Allen P; Graham J; Jacobs R; Boonen S; Pavitt S; Nackaerts O; Marjanovic E; Adams JE; Karayianni K; Lindh C; van der Stelt P; Devlin H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):243-9. PubMed ID: 20659701
[TBL] [Abstract][Full Text] [Related]
19. FRAX-based intervention and assessment thresholds in seven Latin American countries.
Clark P; Denova-Gutiérrez E; Zerbini C; Sanchez A; Messina O; Jaller JJ; Campusano C; Orces CH; Riera G; Johansson H; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):707-715. PubMed ID: 29273826
[TBL] [Abstract][Full Text] [Related]
20. FRAX-derived intervention and assessment thresholds for osteoporosis in ten Middle Eastern countries.
Naseri A; Bakhshayeshkaram M; Salehi S; Heydari ST; Dabbaghmanesh MH; Dabbaghmanesh MM
Arch Osteoporos; 2024 May; 19(1):41. PubMed ID: 38780743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
